How does genetic testing help me choose between semaglutide and other GLP-1 medications
Results can support conversations with the clinician responsible for medication selection, dosing, symptom evaluation, and follow-up care
Retatrutide in the broader GLP-1 landscape Retatrutide does not exist in a vacuum
2.4 Implications for drug discovery strategy Recognizing underexploration as a product of historical context rather than biological inadequacy has important implications for drug discovery strategy
1, 2027, the changes apply to all doses of these medicines and are meant to address access barriers, especially for patients whose out-of-pocket costs are linked to list price including individuals with high-deductible health plans (HDHPs) or coinsurance benefit designs
Efficacy and safety of tirzepatide in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial